Facebook
Twitter
LinkedIn
ForwardThis educational activity is based on case presentations and subsequent small group discussions of patients with hematologic malignancies that are being evaluated, treated and followed in the Department of Hematology and Oncology, and that have diagnostic or follow-up material evaluated in the Division of Hematopathology. The goal of this multimodality approach is to ensure that the best patient care is being delivered by both Hematologists/Oncologists and Pathologists.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
MOC Part II
American Board of Internal Medicine
Public Information About Activities Registered for ABIM MOC Recognition:
“ACCME publishes information about accredited CME activities that have been registered for ABIM MOC via its CME Finder. CME Finder is a publicly available, online search tool that provides a one-stop resource for physician learners seeking to earn MOC points by participating in accredited CME.”
Participation shared with ABIM through PARS:
Individual participants’ information will be shared with ABIM through the ACCME Program and Activity Reporting System (PARS).
“Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 52 Medical Knowledge MOC points n the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."
American Board of Pathology
American Board of Pathology SAMs
The Medical College of Wisconsin is a provider for Self-Assessment Modules as defined by the American Board of Pathology, and has designated this educational activity for a maximum of 50 SAMs credits.
Participation shared with ABPath through PARS:
Individual participants’ information will be shared with ABPath through the ACCME Program and Activity Reporting System (PARS).
Learning objectives are identified for both Hematologists/Oncologists and Hematopathologists.
By completing this activity, Hematologists/Oncologists will be able to:
- Identify appropriate ordering of expensive, ancillary diagnostic testing.
- Describe the salient morphologic, immunophenotypic, cytogenetic and molecular features of common hematologic malignancies.
By completing this activity, Hematopathologists will be able to:
- Discuss emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service.
- Utilize and constantly update themselves with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal patient care.
Planning Committee:
Alexandra Harrington, MD
| Name | Company | Role |
| Ehab Atallah, MD | AbbVie, Takeda, Novartis | Speaker |
| Laura Michaelis, MD | Incyte, Celgene, Pfizer, Novartis, TG Therapeutics, Jazz, BMS, Bioline, ASTEX, Janssen, Millennium, Macrogenics | Speaker |